147 related articles for article (PubMed ID: 32703060)
1. Seroprevalence of poliovirus antibodies before and after polio vaccine switch in 2012 and 2017 in Beijing.
Li J; Zhang Z; Zhang H; Li M; Li X; Lu L; Huang F; Wu J
Hum Vaccin Immunother; 2021 Feb; 17(2):389-396. PubMed ID: 32703060
[TBL] [Abstract][Full Text] [Related]
2. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
[TBL] [Abstract][Full Text] [Related]
3. A national cross-sectional study for poliovirus seroprevalence in the Republic of Korea in 2012: implication for deficiency in immunity to polio among middle-aged people.
Kim HJ; Hwang S; Lee S; Kwon Y; Park K; Park YJ; Bae GR; Lee SW; Jeong YS; Hyeon JY
BMC Infect Dis; 2015 Mar; 15():164. PubMed ID: 25881203
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria.
Giwa FJ; Olayinka AT; Ogunshola FT
Vaccine; 2012 Nov; 30(48):6759-65. PubMed ID: 23000220
[TBL] [Abstract][Full Text] [Related]
5. [Surveillance of immunization effectiveness and titer of type Ⅰ and type Ⅲ polio vaccine in Beijing before and after the adjustment of immunization strategy in 2012-2018].
Li J; Zhang ZJZ; Pan JB; Zhang HR; Li RQ; Li MZ; Lu L; Huang F; Wu J
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jul; 54(7):779-783. PubMed ID: 32842302
[No Abstract] [Full Text] [Related]
6. Seroprevalence of antipolio antibodies among children <15 years of age in border provinces in China.
Wang H; Cui H; Ding Z; Ba P; Zhu S; Wen N; Hao L; Ning J; Zhang J; Yang D; Xu W; Zhang Y; Fan C; Yu W; Liang X; Luo H
Clin Vaccine Immunol; 2013 Jul; 20(7):1070-5. PubMed ID: 23677325
[TBL] [Abstract][Full Text] [Related]
7. Poliomyelitis seroprevalence in high risk populations of India before the trivalent-bivalent oral poliovirus vaccine switch in 2016.
Ahmad M; Verma H; Kunwar A; Soni S; Sinha U; Gawande M; Sethi R; Nalavade U; Sharma D; Bhatnagar P; Bahl S; Deshpande J
Int J Infect Dis; 2021 Jan; 102():337-343. PubMed ID: 33130206
[TBL] [Abstract][Full Text] [Related]
8. Poliovirus antibody levels and lameness among individuals in three regions of Ghana.
Opare JKL; Odoom JK; Akweongo P; Afari EA; Pappoe M
Hum Vaccin Immunother; 2019; 15(9):2050-2059. PubMed ID: 31265356
[No Abstract] [Full Text] [Related]
9. Epidemiological serosurvey of poliovirus in Guangdong, China: A cross-sectional study.
Tan Q; Zhu Q; Zheng H; Zhang B; Wu C; Guo X; Li H; Liu L; Liu Y; Rutherford S; Zheng H
Hum Vaccin Immunother; 2018; 14(11):2644-2648. PubMed ID: 30059644
[TBL] [Abstract][Full Text] [Related]
10. Poliovirus neutralizing antibody levels among individuals in three regions of Ghana.
Opare JK; Akweongo P; Afari EA; Odoom JK
Ghana Med J; 2019 Jun; 53(2):170-180. PubMed ID: 31481814
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of poliovirus antibodies in Nigeria: refining strategies to sustain the eradication effort.
Bolu O; Adamu U; Franka R; Umeokonkwo CD; An Q; Greby S; McDonald S; Mainou B; Mba N; Agala N; Archer WR; Braka F; Etapelong SG; Gashu TS; Siddique AR; Asekun A; Okoye M; Iriemenam N; Wiesen E; Swaminathan M; Ihekweazu C; Shuaib F
Pan Afr Med J; 2023; 45(Suppl 2):2. PubMed ID: 38370104
[TBL] [Abstract][Full Text] [Related]
12. Polio vaccination coverage and seroprevalence of poliovirus antibodies after the introduction of inactivated poliovirus vaccines for routine immunization in Japan.
Satoh H; Tanaka-Taya K; Shimizu H; Goto A; Tanaka S; Nakano T; Hotta C; Okazaki T; Itamochi M; Ito M; Okamoto-Nakagawa R; Yamashita Y; Arai S; Okuno H; Morino S; Oishi K
Vaccine; 2019 Mar; 37(14):1964-1971. PubMed ID: 30827736
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of sequential poliovirus vaccination schedules with different strains of poliomyelitis vaccines in Chongqing, China: a cross-sectional survey.
Xu J; Wang Q; Kuang S; Rong R; Zhang Y; Fu X; Tang W
Hum Vaccin Immunother; 2021 Jul; 17(7):2125-2131. PubMed ID: 33759702
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.
Hotta C; Ogawa T; Shirasawa H
Hum Vaccin Immunother; 2019; 15(5):1154-1159. PubMed ID: 30676843
[TBL] [Abstract][Full Text] [Related]
15. Lower immunity to poliomyelitis viruses in Australian young adults not eligible for inactivated polio vaccine.
Hendry AJ; Beard FH; Dey A; Quinn H; Hueston L; Dwyer DE; McIntyre PB
Vaccine; 2020 Mar; 38(11):2572-2577. PubMed ID: 32037225
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of Poliomyelitis Antibodies Among Children Aged 1 to 4 Years Old and Factors Associated With Poliovirus Susceptibility; Mexican Health and Nutrition Survey, 2012.
Díaz-Quiñónez JA; Díaz-Ortega JL; Cruz-Hervert P; Ferreira-Guerrero E; Delgado-Sánchez G; Ferreyra-Reyes L; López-Martínez I; Torres-Longoria B; Aparicio-Antonio R; Montero-Campos R; Mongua-Rodríguez N; Garcia-Garcia L
Clin Infect Dis; 2018 Oct; 67(suppl_1):S110-S114. PubMed ID: 30376082
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of anti-polio antibodies in children from polio high risk area of Afghanistan: A cross sectional survey 2017.
Hussain I; Mach O; Hamid NA; Bhatti ZS; Moore DD; Oberste MS; Khan S; Khan H; Weldon WC; Sutter RW; Bhutta ZA; Soofi SB
Vaccine; 2018 Apr; 36(15):1921-1924. PubMed ID: 29510918
[TBL] [Abstract][Full Text] [Related]
18. [Study of immunogenicity after primary vaccination by different sequential program of inactivated poliovirus vaccine and oral poliovirus vaccine].
Lu L; Li XM; Liu DL; Zhang HR; Zhang ZJ; Wang HH; Liu F; Ning ZQ; Zhang LW; Chu P; Xie YT; Xu Y; Li J; Pang XH; Deng Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jun; 46(6):510-3. PubMed ID: 22943896
[TBL] [Abstract][Full Text] [Related]
19. Sero-survey of polio antibodies during wild poliovirus outbreak in southern Xinjiang Uygur Autonomous Region, China.
Wang HB; Zhu SL; Zheng JS; Gou AL; Cui H; Zhang Y; Ning GJ; Fan CX; Chen YS; Li KL; Yuan P; Ma C; Ma J; Zheng H; Fan XC; Li XL; Tang HS; Li XL; Zhang F; Yan DM; Wang DY; Cui ZQ; Ren LP; Zhu H; Wang HL; Jiang XH; An HQ; Liu Y; Li J; Xu WB; Wen N; Xu AQ; Luo HM
PLoS One; 2014; 9(7):e80069. PubMed ID: 24991811
[TBL] [Abstract][Full Text] [Related]
20. Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States.
Marin M; Patel M; Oberste S; Pallansch MA
MMWR Morb Mortal Wkly Rep; 2017 Jan; 66(1):23-25. PubMed ID: 28081056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
